IDH1 mutation-associated long non-coding RNA expression profile changes in glioma.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Isocitrate dehydrogenase 1 (IDH1) mutation is a key prognostic indicator in glioma.
• The downstream molecular mechanisms of IDH1 mutations in glioma remain unclear.
• Long non-coding RNAs (lncRNAs) are increasingly recognized as critical regulators in cancer development, including glioma.

Purpose of the Study:

• To investigate differences in lncRNA expression profiles between gliomas with and without IDH1 mutations.
• To identify specific lncRNAs associated with IDH1 mutation status in glioma.
• To explore the functional implications of these IDH1-associated lncRNAs in glioma pathogenesis.

Main Methods:

• Utilized a previously established lncRNA mining approach for lncRNA profiling.
• Analyzed three public glioma microarray datasets to compare lncRNA expression.
• Performed differential expression analysis between IDH1-mutant and IDH1-wild-type glioma samples.

Main Results:

• Identified 14 and 9 differentially expressed lncRNA probe sets in astrocytic and oligodendroglial tumors, respectively (fold change ≥ 1.5, FDR ≤ 0.1).
• Confirmed the differential expression of these lncRNAs in independent testing datasets.
• Functional analysis indicated involvement of these lncRNAs in crucial cellular processes like metabolism, cell growth, and apoptosis.

Conclusions:

• lncRNA expression profiles differ significantly based on IDH1 mutation status in glioma.
• IDH1 mutation-associated lncRNAs play potential roles in gliomagenesis.
• These findings contribute to understanding the molecular pathogenesis of IDH1-mutated gliomas.